Plant-derived medication for LUTS
This article has no abstract so we have provided the first paragraph of the full text.
A lipido-sterolic extract of the American dwarf palm tree Serenoa repens is increasingly used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). This approach is thought to alleviate LUTS without producing the negative effects—in particular the impact on sexual function—associated with more traditional therapies such as 
-blockers and 5-reductase inhibitors. Gerber and Fitzpatrick have reviewed the clinical data available on S. repens extract to assess its potential in patients with BPH.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.